| Planning
  	
	      	
        	
        		
        		   Tuesday, November 26, 2019        	    
        	 
        	
    	      	
    	        	
    	          		| Time | Event | (+) |  
        	          	| 08:15 - 09:00 | Welcome coffee |  |  
        	          	| 09:00 - 10:00 | Presentation of Curamus programs |  |  
        	          	| 09:00 - 09:05 | Structuring SiRIC Curamus - Marc Sanson |  |  
        	          	| 09:05 - 09:15 | Neuro-oncology program - Marc Sanson |  |  
        	          	| 09:15 - 09:25 | Rare Immunohematological cancers program - Véronique Leblond |  |  
        	          	| 09:25 - 09:35 | Microsatellite Instability and Cancer program - Alex Duval |  |  
        	          	| 09:35 - 09:45 | Medical Humanities Integrated Group - Karine Berthelot-Guiet |  |  
        	          	| 09:45 - 10:00 | Questions, discussion |  |  
        	          	| 10:00 - 11:00 | Basic research - Genetics of tumors |  |  
        	          	| 10:00 - 10:10 | Genomic and functional analysis of chordoid gliomas - Bertille Bance |  |  
        	          	| 10:10 - 10:20 | Functional consequences of a recurrent SPI1 mutation in Waldenström’s macroglobulinemia  - Damien Roos-Weil |  |  
        	          	| 10:20 - 10:30 | Genomic MSI: Gene Splicing Abnormalities in Colorectal Cancer with Microsatellite Instability - Vincent Jonchère |  |  
        	          	| 10:30 - 10:40 | What is this object called ‘’Tumor microenvironment’’? The view from history and philosophy of science - Anouk Barberousse |  |  
        	          	| 10:40 - 11:00 | Questions, discussion |  |  
        	          	| 11:00 - 11:30 | Coffee break |  |  
        	          	| 11:30 - 12:30 | Prediction & Innovative Diagnosis |  |  
        	          	| 11:30 - 11:40 | Non invasive diagnosis of gliomas by spectro-MRI - Francesca Branzoli |  |  
        	          	| 11:40 - 11:50 | Development of a NGS-based method for IGHV mutational status assessment in chronic lymphocytic leukemia - Frederic Davi |  |  
        	          	| 11:50 - 12:00 | Identification of the MSI phenotype at the time of next-generation sequencing - Toky Ratovomanana |  |  
        	          	| 12:00 - 12:10 | Do cancer biomarkers have a philosophical nature? - Jean-Cassien Billier |  |  
        	          	| 12:10 - 12:30 | Questions, discussion |  |  
        	          	| 12:30 - 13:40 | Lunch |  |  
        	          	| 13:40 - 14:40 | Innovative Therapies, Follow-up and Quality of Life |  |  
        	          	| 13:40 - 13:50 | MMR deficiency in gliomas, consequences for treatment - Mehdi Touat |  |  
        	          	| 13:50 - 14:00 | Immune checkpoint inhibitors in people living with HIV - Baptiste Abbar |  |  
        	          	| 14:00 - 14:10 | MSI/dMMR digestive cancers treated by checkpoint inhibitors - Raphaël Colle |  |  
        	          	| 14:10 - 14:20 | Patient’s information and expertise. The case of histiocytosis - Renaud Debailly & Fleur Cohen |  |  
        	          	| 14:20 - 14:40 | Questions, discussion |  |  
        	          	| 14:40 - 15:10 | Coffee break |  |  
        	          	| 15:10 - 16:30 | Invited speakers |  |  
        	          	| 15:10 - 15:40 | The drivers of oncogenesis of brain tumors: a model for precision medicine - Antonio Iavarone |  |  
        	          	| 15:40 - 16:10 | Philosophy of Cancer : A Dynamic and Relational View - Marta Bertolaso |  |  
        	          	| 16:10 - 16:30 | Questions, discussion |  |  
        	          	| 16:30 - 16:35 | Closing remarks - Alex Duval |  |  |